Identifying diagnostic testing gaps for antiphospholipid syndrome within a single healthcare system

Antiphospholipid antibody syndrome (APS) is a rare disease with significant morbidity and the possibility of mortality. While there are no established diagnostic criteria for use in clinical settings, there is a large body of global research organized by the American College of Rheumatology and Eur